Thyme Care Raises $97M to Break Through Cancer Care's Biggest Bottlenecks | LEARN MORE
In OncoDaily, Senior Medical Director Samyukta Mullangi (also an oncologist at Tennessee Oncology) discusses how clinical decision support tools—specifically AI systems like OpenEvidence—can enhance modern cancer care. She argues that while such tools already streamline literature search, summarization, and citation, they lack integration with guideline databases (e.g. NCCN) and advanced comparative trial synthesis.